Hyung-In Moon, the South Korean plant compound researcher who came up with fake email addresses so that he could do his own peer review, has retracted twenty more papers, all in Immunopharmacology and Immunotoxicology, an Informa Healthcare title.
Here are the papers: Continue reading 20 more retractions for scientist who made up email addresses so he could review his own papers
The Journal of Experimental Medicine has issued a correction for a 2011 paper by Michael Karin, a prominent cancer researcher at the University of California, San Diego, after learning about a “clerical error” in one of the figures.
According to the notice for the article, “Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation,” Continue reading Authors, including highly cited cancer researcher, blame “clerical error” for image mixup in paper
Last month, we brought you the story of Guang-Zhi He of the Guiyang College of Traditional Chinese Medicine in China, an enterprising fellow who got caught faking the email addresses of potential peer reviewers. At the time, Elsevier, who published journals where He published, told us there would be several retractions other than the one we reported on.
Three of those have appeared, in the same journal, Experimental Parasitology, and saying the same thing: Continue reading More shoes drop for Chinese author who made up peer reviewer addresses
Blood has pulled a paper 2007 paper from a group of Spanish researchers, one of whom appears to have been manipulating images.
The group’s work became the focus of expressions of concern from the Journal of Clinical Oncology this spring and in 2010.
The article, “Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia,” purported to show “a role of abnormal Wnt signaling in ALL and establish a group of patients with a significantly worse prognosis (methylated group)” and earned a commentary on the significance of the findings.
But as the notice explains, the first author lifted and manipulated a figure from a previously published article: Continue reading A Wnt-er’s tale: Blood pulls second signaling paper from Spanish scientists over image fakery
University of Alabama researchers have retracted a paper claiming that a grape skin seed compound might have anti-prostate cancer effects.
Here’s the notice for “Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NFκB”: Continue reading Authors retract prostate cancer-grape seed compound paper for figure presentation error
Laurence Klotz, a prominent urologist at the University of Toronto who studies the prostate specific antigen (PSA), has corrected a paper after reusing his own words from an earlier review.
Here’s the correction, from the Journal of Clinical Oncology (JCO): Continue reading Duplication earns highly cited prostate cancer researcher a correction in JCO
Although he’s in no danger of breaking the current record of 172 likely retractions, Diederik Stapel now has 20 to his, um, credit.
The September 2012 issue of the Journal of Personality and Social Psychology features these seven: Continue reading And then there were 20: Diederik Stapel retraction count keeps growing
Anil Potti, the former Duke cancer researcher who has now retracted or corrected 18 papers amidst investigations into his work, is now working at a Grand Forks, North Dakota, cancer center.
The Grand Forks Herald reports that Potti has worked at the Cancer Center of North Dakota since May. His new boss, William Noyes, told the paper that Continue reading Anil Potti resurfaces with job at North Dakota cancer center
Today’s Retraction Watch, to paraphrase Sesame Street, is brought to you by the number 13.
Earlier, we reported on several retractions from Diederik Stapel that bring his total to that number, and now we’ve learned about number 13 for Dipak Das. Das is of course the UConn researcher who was found to have committed 145 counts of misconduct in his studies of the red wine compound resveratrol and other subjects.
Here’s the notice, from The Journal of Nutritional Biochemistry, for “Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose:” Continue reading Seeing red (wine): Another retraction for Dipak Das, making count 13
The anticipation of having one’s blood pressure measured can cause it to spike.
So, evidently, can errors in data processing — on a national scale.
Hypertension, a journal published by the American Heart Association, has retracted a 2011 paper looking at the implications of blood pressure management guidelines after the authors discovered they had bungled the merging of their data files.
As the notice explains: Continue reading Hypertension retracts paper over data glitch